Oxford BioMedica
Kevin Malabre has an extensive background in upstream process development and bioprocessing, with experience in companies such as Oxford Biomedica, UCB, GSK, and Novartis Vaccines. Kevin has worked on improving protein yields for vaccines, conducted fermentations in bioreactors, and implemented scale-down models. Kevin has also managed teams, mentored junior staff, and worked on various analytical tasks using chromatography systems. Their educational background includes a degree in Biotechnology Engineering from Polytech Clermont.
This person is not in the org chart
This person is not in any offices
Oxford BioMedica
2 followers
Oxford Biomedica (LSE: OXB) is a leading, fully integrated, cell and gene therapy group.